If you are a man in your 40s and feel like your body is fighting you — carrying more fat around the midsection despite not eating more, recovering slower from workouts, sleeping worse, and noticing that your skin and joints are not what they were — you are not imagining it. You are experiencing the compound effect of two major hormonal declines that begin in your 30s and accelerate through your 40s and beyond.
Peptide protocols designed specifically for this hormonal context can meaningfully address these changes. This guide covers what is actually declining, which peptides target which mechanisms, exact protocols used by men over 40, and what you can realistically expect. No hype — just what the evidence supports.
The Hormonal Reality of Being a Man Over 40
Two systems decline in parallel, and they interact with each other in ways that amplify the effects of each:
Testosterone Decline
Total testosterone drops at a rate of 1–2% per year after age 30. By 45, many men have testosterone levels 15–30% below their peak. By 55, the decline is often 30–40%. Free testosterone — the biologically active fraction — declines even faster because sex hormone-binding globulin (SHBG) increases with age, binding more testosterone and reducing what is available to tissues.
The consequences are not just libido-related. Lower testosterone increases fat accumulation (particularly visceral fat), reduces muscle protein synthesis, impairs bone mineral density, affects mood and cognitive sharpness, and worsens insulin sensitivity. Every symptom feeds the others — more fat means more aromatization of testosterone to estrogen, which further suppresses testosterone production.
Growth Hormone Decline
Growth hormone (GH) secretion peaks in adolescence and declines at roughly 14% per decade after age 20. By 40, most men are secreting 50–60% less GH than they did at 20. IGF-1 (insulin-like growth factor 1), the primary downstream mediator of GH effects, tracks this decline closely.
GH decline contributes to: increased body fat percentage (especially truncal), reduced lean muscle mass, slower injury recovery, poor sleep quality (GH is secreted primarily during slow-wave sleep, and low GH disrupts that architecture), skin thinning and collagen loss, and impaired immune function. The GH axis decline is insidious because it happens slowly enough that most men attribute the symptoms to "just aging."
The GH Axis Peptides: Ipamorelin vs CJC-1295 vs Sermorelin
GH secretagogue peptides work by stimulating your pituitary to produce and release more of your own growth hormone. They do not introduce exogenous GH — they amplify your natural GH pulses. This distinction matters: the pituitary's natural feedback mechanisms remain intact, making GH secretagogues considerably safer than exogenous GH injections at equivalent dose ranges.
- Sermorelin: The oldest and most studied GH secretagogue. Mimics GHRH (growth hormone-releasing hormone). Gentle, gradual effect. Good starter option but less potent than newer peptides. Half-life is very short (minutes), requiring precise timing around sleep.
- Ipamorelin: A GHRP (growth hormone-releasing peptide) that stimulates GH release via the ghrelin receptor. Highly selective — it does not significantly raise cortisol or prolactin the way older GHRPs like GHRP-6 did. Clean GH pulse with minimal side effects. The gold standard GHRP for most users.
- CJC-1295:A GHRH analog with a much longer half-life than sermorelin. Available in two forms: CJC-1295 with DAC (drug affinity complex), which has a ~8-day half-life and produces a continuous GH "bleed," and CJC-1295 without DAC (also called Mod GRF 1-29), which has a ~30-minute half-life and produces a more natural pulse. Most practitioners prefer the no-DAC version for preserving pulsatile GH release patterns.
Why Ipamorelin + CJC-1295 is the standard combination: They work via different receptor systems and have a synergistic effect when stacked. CJC-1295 (no-DAC) amplifies GHRH signaling; Ipamorelin amplifies the ghrelin pathway. Used together, the GH pulse is significantly larger than either alone — studies suggest 2–4x the amplitude versus placebo. This combination has the strongest practical track record among men over 40 using peptides for body composition and recovery.
Protocol for Men Over 40: GH Axis
The standard protocol most men over 40 use for GH optimization:
- Ipamorelin: 200 mcg subcutaneous injection
- CJC-1295 (no-DAC / Mod GRF 1-29): 100 mcg subcutaneous injection
- Timing: 30–60 minutes before sleep, on an empty stomach (no food for 2 hours prior)
- Frequency: 5 days on / 2 days off (some practitioners use daily; evidence does not strongly favor one over the other)
- Cycle length: 12 weeks on, 4 weeks off minimum
- Injection site: Subcutaneous fat of the abdomen or upper thigh; rotate sites
The pre-sleep timing is not arbitrary. The largest natural GH pulse of the day occurs 1–2 hours after sleep onset. Timing the peptide injection to amplify this pulse maximizes total GH output while maintaining the natural circadian pattern. Food raises insulin, which suppresses GH release — hence the fasting requirement.
Testosterone Support: Gonadorelin
Gonadorelin is a synthetic form of GnRH (gonadotropin-releasing hormone) — the hypothalamic signal that tells the pituitary to release LH and FSH, which in turn tell the testes to produce testosterone. It works upstream of the testosterone production pathway.
This distinguishes it fundamentally from TRT (testosterone replacement therapy). TRT introduces exogenous testosterone, which suppresses the HPG (hypothalamic-pituitary-gonadal) axis and leads to testicular atrophy and loss of endogenous production. Gonadorelin stimulates the axis rather than replacing it. The result: your own testes produce more testosterone, LH and FSH are preserved, and fertility is maintained — all without the suppressive feedback loop of exogenous androgens.
For men with mild-to-moderate testosterone decline (not severe hypogonadism), gonadorelin can meaningfully improve natural testosterone output. It is also widely used alongside TRT to preserve testicular function and prevent the suppression of natural production. Typical dosing: 100 mcg subcutaneous injection 2x per week.
Joint and Tendon Recovery: BPC-157
By 40, most active men are carrying some degree of cumulative joint and tendon damage — rotator cuff irritation, patellar tendinopathy, knee cartilage wear, chronic low back issues. Recovery from these injuries slows significantly with age as collagen synthesis rates and tissue perfusion decline.
BPC-157 is the peptide with the most consistent evidence for accelerating tendon and ligament healing in animal models, and arguably the most used peptide among athletes over 40 for this specific purpose. While human clinical trial data remains limited (see our full BPC-157 research article), the mechanistic rationale is sound and the anecdotal record among practitioners is substantial.
Protocol: BPC-157 250 mcg subcutaneous or intramuscular injection, twice daily (morning and evening), for 4–8 weeks targeting an acute injury. For chronic joint maintenance, some men use 200 mcg once daily on an ongoing basis. Injection near the site of injury (but not directly into the joint) may improve local bioavailability.
Fat Loss: GLP-1 Options
Men over 40 with significant fat to lose — particularly visceral abdominal fat — may benefit from adding a GLP-1 receptor agonist to their protocol. The visceral fat that accumulates with testosterone and GH decline responds well to GLP-1-mediated appetite reduction.
Semaglutide is the most conservative starting point: begin at 0.25 mg subcutaneous once weeklyfor 4 weeks, then titrate to 0.5 mg for 4 weeks, then 1.0 mg if tolerated. Most men over 40 see meaningful fat loss at 0.5–1.0 mg without needing to push to maximum doses. Combine with the GH protocol above to offset the lean mass loss that can occur with aggressive caloric restriction — the GH axis support helps maintain muscle during the cut.
Lab Monitoring: What to Track
Any man over 40 using this protocol should establish baseline labs and monitor throughout. Essential panels:
- IGF-1: The best proxy for GH status. Baseline before starting; recheck at 8–12 weeks. Target: mid-to-upper normal range for your age.
- Total Testosterone: Baseline and quarterly. Normal reference range is broad (300–1000 ng/dL); what matters more is your trend relative to baseline.
- Free Testosterone: More informative than total T for men over 40 with high SHBG. Calculate from total T, SHBG, and albumin if direct free T is unavailable.
- LH and FSH: Establishes whether low T is primary (testicular) or secondary (hypothalamic/pituitary). Guides whether gonadorelin or other interventions are appropriate.
- Estradiol (E2): Testosterone aromatizes to estrogen, especially in the presence of excess body fat. Elevated E2 worsens fat gain and suppresses T. Track alongside testosterone.
- Fasting glucose and HbA1c: GH raises insulin resistance at higher doses; GLP-1s lower it. Know your baseline before combining both classes.
Realistic Expectations: What Each Compound Delivers
| Compound | Primary Benefit for Men 40+ | Realistic Timeline | Magnitude |
|---|---|---|---|
| Ipamorelin + CJC-1295 | Sleep quality, recovery, body composition, skin | 4–8 weeks for sleep; 8–12 weeks for body comp | Moderate but consistent |
| Gonadorelin | Natural testosterone support, libido, mood | 6–10 weeks for measurable T increase | Moderate (10–25% T increase typical) |
| BPC-157 | Injury healing, joint pain, gut health | 2–4 weeks for acute symptoms; 6–8 for tissue remodeling | Variable; highest in acute injuries |
| Semaglutide | Fat loss, appetite control, visceral fat reduction | 4 weeks for appetite effect; 12–24 weeks for significant fat loss | Significant (10–15% body weight over 6–12 months) |
Do not try to run everything at once. Start with the foundation: Ipamorelin 200 mcg + CJC-1295 100 mcg before bed for 12 weeks. Get baseline labs (IGF-1, total T, free T, LH, FSH, E2) before you start and recheck at week 12. Most men notice meaningful improvement in sleep quality within 2–3 weeks, followed by gradual improvements in recovery and body composition. Add BPC-157 if you have a specific injury or chronic joint issue. Add gonadorelin if your baseline labs show low-normal T and preserved LH/FSH. Add a GLP-1 only if you have significant fat to lose and want to accelerate that component.
For the combined Ipamorelin + CJC-1295 stack with reconstitution guide and dosing calculator, see our Ipamorelin/CJC product page. For body composition optimization including peptide timing around training, visit our body composition guide. For a full GH optimization stack including advanced options, see our GH optimization stack guide.